Skip to main content
. 2021 May 12;37(10):3019–3025. doi: 10.1007/s10554-021-02279-z

Table 1.

Study demographics and pulmonary haemodynamics

All Alive Dead P-value*
N 116 55 61
Age (yrs) 73 ± 7 71 ± 8 75 ± 7 0.018
Gender (Male) 50 (43%) 15 (27%) 35 (57%) 0.001
BMI (kg/m2) 31 ± 6 31 ± 7 30 ± 6 0.284
Heart rate (bpm) 65 ± 12 65 ± 13 65 ± 11 0.800
Diabetes mellitus 30 (26%) 13 (24%) 17 (28%) 0.607
Hypercholesterolaemia 24 (21%) 11 (20%) 13 (21%) 0.863
Hypertension 78 (67%) 41 (75%) 37 (61%) 0.056
IHD 20 (17%) 9 (16%) 11 (18%) 0.814
Atrial fibrillation 82 (71%) 32 (58%) 50 (82%) 0.009
Stroke 8 (7%) 3 (5%) 5 (8%) 0.565
Invasive haemodynamics
Mean RA (mmHg) 15 ± 5 14 ± 5 17 ± 5 0.004
Mean PAP (mmHg) 42 ± 10 39 ± 9 45 ± 10 0.002
PCWP (mmHg) 23 ± 5 23 ± 5 22 ± 5 0.327
DPG (mmHg) 1 ± 7 -1 ± 6 3 ± 7  < 0.001
TPG (mmHg) 19 ± 9 16 ± 7 22 ± 9  < 0.001
Cardiac index (L/min/m2) 2.8 ± 1 2.9 ± 1.1 2.7 ± 0.8 0.432
PVR (Wood unit) 4.2 ± 2.95 3.16 ± 1.7 5 ± 3.5  < 0.001
O2 saturation (arterial) 95 ± 4 95 ± 3 94 ± 4 0.071
O2 saturation (venous) 65 ± 9 68 ± 8 63 ± 10 0.005

Categorical comparisons done by Chi-square test

BMI Body mass index, IHD Ischaemic heart disease, RA right atrial, PAP pulmonary artery pressure, PCWP pulmonary capillary wedge pressure, DPG diastolic pulmonary gradient, TPG transpulmonary pressure gradient, PVR pulmonary vascular resistance

*P-value is for T-Test comparison between Alive and Dead cohorts